EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome)

PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

Pablo Avanzas

Effect of Loading Dose of Atorvastatin Prior to Planned PCI: The SECURE-PCI Randomized Clinical Trial

Alberto J. Lorenzatti

Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes

Pablo Avanzas

Use of Aspirin to Reduce Risk of Initial Vascular Events in Patients at Moderate Risk of Cardiovascular Disease (ARRIVE Trial)

Pablo Avanzas

Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients (CAMELLIA–TIMI 61)

Amelia Carro

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness (MARINER)

Pablo del Castillo Vazquez,  Antoni Martínez-Rubio

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia: The REDUCE-IT trial

Andréa Araujo Brandao

ESCaPE CMD – Autologous CD34 Cell Transfer for the Management of Microvascular Angina

JC Kaski

SGLT2 Inhibitors Reduce Blood Pressure and Left Ventricular Mass

Thomas Kahan

Targeted Anti-Cytokine Therapies for Treatment of Atherothrombosis

Pablo Avanzas

Rivaroxaban in Peripheral Artery Disease after Revascularization

Gheorghe-Andrei Dan